Hypoxia augments TNF-alpha-mediated endothelin-1 release and cell proliferation in human optic nerve head astrocytes

Biochem Biophys Res Commun. 2004 Jun 4;318(3):642-8. doi: 10.1016/j.bbrc.2004.04.073.

Abstract

The effect of hypoxia (24 h) on TNF-alpha-mediated release of endothelin-1 (ET-1) from human optic nerve head astrocytes (hONAs) and TNF-alpha- and ET-1-induced hONA proliferation was determined. ET-1 synthesis and release was quantitated using ELISA while TNF-alpha (10 nM)- and ET-1 (100 nM)-mediated hONA proliferation was assessed by CellTiter 96 aqueous one-solution cell proliferation assay, respectively. hONAs appeared to be more rounded with fewer processes following 24 h hypoxia compared to thodr seen in normoxia. Hypoxia enhanced TNF-alpha-mediated ET-1 synthesis and release (by 5-fold) and also significantly increased TNF-alpha- and ET-1-mediated hONA proliferation. PD142893 (1 microM), an ET(A/B) receptor antagonist, blocked ET-1-mediated hONA proliferation both under normoxia and hypoxia, while doing so only under normoxia following TNF-alpha treatment. Also, U0126 (10 microM; an upstream ERK1/2 inhibitor) completely blocked agonist-induced hONA proliferation in normoxia and partially blocked the same in hypoxia. These results demonstrate for the first time that hONAs secrete ET-1 and that TNF-alpha and hypoxia can regulate its levels. Moreover, hypoxia augments the proliferative responses of hONAs to TNF-alpha and ET-1. These agonist-mediated effects following hypoxia could contribute to astroglial activation as seen in glaucomatous optic nerve heads.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Aspartic Acid Endopeptidases / antagonists & inhibitors
  • Astrocytes / drug effects
  • Astrocytes / metabolism*
  • Astrocytes / ultrastructure
  • Butadienes / pharmacology
  • Cell Division / drug effects
  • Cell Division / physiology
  • Cell Hypoxia / physiology
  • Cell Line, Tumor
  • Cells, Cultured
  • Cycloheximide / pharmacology
  • Dactinomycin / pharmacology
  • Endothelin Receptor Antagonists
  • Endothelin-1 / metabolism*
  • Endothelin-Converting Enzymes
  • Enzyme Inhibitors / pharmacology
  • Glycopeptides / pharmacology
  • Humans
  • Metalloendopeptidases
  • Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • Nitriles / pharmacology
  • Oligopeptides / pharmacology
  • Optic Disk / cytology
  • Optic Disk / drug effects
  • Optic Disk / metabolism*
  • Protease Inhibitors / pharmacology
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • Butadienes
  • Endothelin Receptor Antagonists
  • Endothelin-1
  • Enzyme Inhibitors
  • Glycopeptides
  • Nitriles
  • Oligopeptides
  • Protease Inhibitors
  • Tumor Necrosis Factor-alpha
  • U 0126
  • PD 142893
  • Dactinomycin
  • Cycloheximide
  • Mitogen-Activated Protein Kinases
  • Aspartic Acid Endopeptidases
  • Metalloendopeptidases
  • Endothelin-Converting Enzymes
  • phosphoramidon